http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102557977-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab5a7b5f39157c7a9ce35b4db7b84162
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C201-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C201-08
filingDate 2010-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1051780cbe7ceac608cb19e477e1f77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a8633babb3ecd4b6ba47d077a2bdf40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d5a69698ca1e6809cf6e5afc6e2909c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_292534d42c77cd55200ed58325ed7b63
publicationDate 2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102557977-A
titleOfInvention Synthetic intermediate of erlotinib and preparation method thereof
abstract The present invention relates to a kind of technique of chemically synthesizing medicine, particularly relate to a kind of synthetic new technique of antineoplastic drug Erlotinib Hydrochloride (Erlotinib Hydrochloride) and new intermediate, the starting material of this technique is cheap and easy to get, and the conditions in the reaction process The device is mild and has no special requirements, and is suitable for industrial production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211648-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102887835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107056724-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103265456-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107235921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107043356-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102827086-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107056724-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107043356-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107266375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014183560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107235921-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105801495-A
priorityDate 2010-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008125867-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005080262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008007441-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007138612-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007138613-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009007984-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407986136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413448778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70927755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466400781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453658850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147234431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161530576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45140307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428316267

Total number of triples: 50.